Mary Sontrop has experience in the biopharmaceutical sector across manufacturing operations, quality and business integration.
She has held executive roles at CSL Limited where she participated in international acquisitions, turned around unprofitable manufacturing operations. As head of CSL's Australia and New Zealand pharmaceutical business, she and her team delivered the human papilloma virus immunisation programs and obtained FDA approval to manufacture and export seasonal and pandemic influenza vaccines.
Ms Sontrop holds a Bachelor of Applied Science, Graduate Diplomas in Quality Management and Administration (Health), a Master of Business Administration, and is a graduate of the Australian Institute of Company Directors.